Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.47
Delayed Data
As of Aug 28
 +0.0179 / +3.96%
Today’s Change
0.38
Today|||52-Week Range
0.69
-16.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization37.6K90.0K39.5K85.0K
 
 
 
 
 
 
Operating ExpensesGross Income-37.6K-90.0K-39.5K-85.0K
 
 
 
 
 
General Expenses12.9M15.6M21.4M28.9M
 
 
 
 
 
Research And Development5.8M8.1M12.9M19.4M
 
 
 
 
 
Total Operating Expenses13.0M15.7M21.5M29.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-15.7M-21.5M-29.0M
 
 
 
 
 
Extraordinary Credit0.0069.6K0.000.00
 
 
Extraordinary Charge-410.9K0.00-79.6K-271.0K
 
 
 
 
Other Expenses60.4K-5.0K-1.4K508.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.3M-15.6M-21.5M-28.7M
 
 
 
 
 
Net Income-13.3M-15.6M-21.5M-28.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.2M47.6M76.6M122.4M
 
 
 
 
 
Shares To Calculate EPS Diluted28.2M47.6M76.6M122.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.47-$0.33-$0.28-$0.23
 
 
 
 
 
EPS Diluted-$0.47-$0.33-$0.28-$0.23